Contour blood glucose monitoring system

Contour is a globally recognized brand specializing in blood glucose monitoring systems designed to assist individuals in managing diabetes. The brand was originally established under the Bayer AG healthcare division, emerging from their long history of innovation in medical diagnostics. The system is known for its high accuracy and user-friendly features like 'Second-Chance' sampling.

In 2016, Bayer sold its Diabetes Care business to Panasonic Healthcare Holdings, a company backed by KKR and Panasonic. This transition led to the formation of Ascensia Diabetes Care, which now serves as the dedicated global entity managing the Contour portfolio. Manufacturing is primarily concentrated in Switzerland, though various components and regional packaging may occur across a global supply chain.

Today, Ascensia Diabetes Care is the ultimate owner of the brand. Headquartered in Switzerland, the company continues to evolve the Contour line, including the Contour Next and Contour Plus series, integrating digital health solutions to provide better data insights for patients and healthcare providers worldwide.